...
首页> 外文期刊>Journal of Pain Research >Activation of spinal dorsal horn P2Y13 receptors can promote the expression of IL-1β and IL-6 in rats with diabetic neuropathic pain
【24h】

Activation of spinal dorsal horn P2Y13 receptors can promote the expression of IL-1β and IL-6 in rats with diabetic neuropathic pain

机译:脊髓背角P2Y 13 受体的激活可促进糖尿病性神经痛大鼠的IL-1β和IL-6表达

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objective: The dorsal horn P2Y13 receptor is involved in the development of pain behavior induced by peripheral nerve injury. It is unclear whether the expression of proinflammatory cytokines interleukin (IL)-1β and IL-6 at the spinal dorsal horn are influenced after the activation of P2Y13 receptor in rats with diabetic neuropathic pain (DNP). Methods: A rat model of type 1 DNP was induced by intraperitoneal injection of streptozotocin (STZ). We examined the expression of P2Y13 receptor, Iba-1, IL-1β, IL-6, JAK2, STAT3, pTyr1336, and pTyr1472 NR2B in rat spinal dorsal horn. Results: Compared with normal rats, STZ-diabetic rats displayed obvious mechanical allodynia and the increased expression of P2Y13 receptor, Iba-1, IL-1β, and IL-6 in the dorsal spinal cord that was continued for 6 weeks in DNP rats. The data obtained indicated that, in DNP rats, administration of MRS2211 significantly attenuated mechanical allodynia. Compared with DNP rats, after MRS2211 treatment, expression of the P2Y13 receptor, Iba-1, IL-1β, and IL-6 were reduced 4 weeks after the STZ injection. However, MRS2211 treatment did not attenuate the expression of the P2Y13 receptor, Iba-1, IL-1β, and IL-6 at 6 weeks after the STZ injection. MRS2211 suppressed JAK2 and STAT3 expression in the early stage, but not in the later stage. Moreover, pTyr1336 NR2B was significantly decreased, whereas pTyr1472 NR2B was unaffected in the dorsal spinal cord of MRS2211-treated DNP rats. Conclusion: Intrathecal MRS2211 produces an anti-nociceptive effect in early-stage DNP. A possible mechanism involved in MRS2211-induced analgesia is that blocking the P2Y13 receptor downregulates levels of IL-1β and IL-6, which subsequently inhibit the activation of the JAK2/STAT3 signaling pathway. Furthermore, blocking the activation of the P2Y13 receptor can decrease NR2B-containing NMDAR phosphorylation in dorsal spinal cord neurons, thereby attenuating central sensitization in STZ-induced DNP rats.
机译:目的:背角P2Y 13 受体参与周围神经损伤引起的疼痛行为的发展。尚不清楚糖尿病神经性疼痛(DNP)大鼠中P2Y 13 受体激活后,脊髓背角促炎性细胞因子白介素(IL)-1β和IL-6的表达是否受到影响。方法:腹膜内注射链脲佐菌素(STZ)建立1型DNP大鼠模型。我们检查了P2Y 13 受体,Iba-1,IL-1β,IL-6,JAK2,STAT3,pTyr 1336 和pTyr 1472 的表达 NR2B在大鼠脊髓背角中。结果:与正常大鼠相比,STZ-糖尿病大鼠表现出明显的机械性异常性疼痛,并且脊髓背侧P2Y 13 受体,Iba-1,IL-1β和IL-6的表达增加。在DNP大鼠中持续6周。获得的数据表明,在DNP大鼠中,MRS2211的给药显着减轻了机械性异常性疼痛。与DNP大鼠相比,MRS2211治疗后STZ注射4周后P2Y 13 受体,Iba-1,IL-1β和IL-6的表达降低。然而,MRS2211处理并没有减弱STZ注射后6周时P2Y 13 受体,Iba-1,IL-1β和IL-6的表达。 MRS2211在早期抑制了JAK2和STAT3的表达,但在后期却没有。此外,pTyr 1336 NR2B明显降低,而pTyr 1472 NR2B在经MRS2211治疗的DNP大鼠的背脊髓中未受影响。结论:鞘内注射MRS2211对早期DNP具有抗伤害感受作用。 MRS2211引起的镇痛的可能机制是阻断P2Y 13 受体下调IL-1β和IL-6的水平,从而抑制JAK2 / STAT3信号通路的激活。此外,阻断P2Y 13 受体的激活可以减少脊髓背神经元中含NR2B的NMDAR磷酸化,从而减弱STZ诱导的DNP大鼠的中枢敏化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号